Mumbai, June 10th 2025: Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services, today announced the successful completion of its Clinical Research Organization (CRO) registration with the Central Drugs Standard Control Organization (CDSCO). This registration complies with the new G.S.R 581 (E) […]
The post Parexel Successfully Completes CDSCO Registration in India first appeared on Business News Week.